Hostname: page-component-6766d58669-bp2c4 Total loading time: 0 Render date: 2026-05-24T07:53:34.959Z Has data issue: false hasContentIssue false

Initial UK experience of patient satisfaction with the Meniett® device for Ménière's disease treatment

Published online by Cambridge University Press:  11 June 2010

M A Buchanan*
Affiliation:
Departments of Otolaryngology, Norfolk and Norwich University Hospital, and James Paget University Hospital, Great Yarmouth, UK
A Rai
Affiliation:
Departments of Otolaryngology, Norfolk and Norwich University Hospital, and James Paget University Hospital, Great Yarmouth, UK
P R Prinsley
Affiliation:
Departments of Otolaryngology, Norfolk and Norwich University Hospital, and James Paget University Hospital, Great Yarmouth, UK
*
Address for correspondence: Mr M A Buchanan, Beck House, 137B Cambridge Road, Great Shelford, Cambridge CB22 5JJ, UK. E-mail: malcolm_buchanan123@hotmail.com

Abstract

Objectives:

To evaluate patient satisfaction and symptom improvement following treatment of Ménière's disease with the Meniett® device.

Methods:

Retrospective, questionnaire-based audit and analysis of unilateral Ménière's disease patients’ records, following on from a previous study from our departments on intra-tympanic gentamicin for Ménière's disease, using the Vertigo Symptom Scale and Glasgow Benefit Inventory as outcome measures.

Results:

Of 33 consecutive patients treated with the Meniett® device for four to six weeks, 30 responded to the questionnaires (90.9 per cent). Respondents’ mean Vertigo Symptom Scale score was 0.7 (range 0–2.1), and their mean Glasgow Benefit Inventory general subscale score was 24.1. Nineteen (63.3 per cent) patients felt that the device had alleviated their vertigo and tinnitus.

Conclusions:

This is the first UK study of the effectiveness of the Meniett® device in treating Ménière's disease. It shows that the Meniett® device is a well tolerated, useful and minimally invasive means of treating Ménière's disease after medical treatment has failed, and before more potentially cochleo- and vestibulo-toxic therapies and invasive procedures are utilised.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable